Clinical characteristics and genetic analysis of 22 Chinese pedigrees affected with Neurofibromatosis type I.
10.3760/cma.j.cn511374-20250825-00511
- Author:
Bingjie HU
1
;
Xianhong DING
;
Yang LU
;
Hongliang CHEN
;
Shuaishuai CHEN
;
Mengyi XU
;
Yicheng FANG
;
Bo SHEN
Author Information
1. Department of Laboratory Medicine, Taizhou Hospital Affiliated to Wenzhou Medical University, Taizhou, Zhejiang 317000, China. shenb@enzemed.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Neurofibromatosis 1/pathology*;
Male;
Female;
Pedigree;
Adult;
Child;
Child, Preschool;
Middle Aged;
Adolescent;
Infant;
Young Adult;
Neurofibromin 1/genetics*;
Phenotype;
Asian People/genetics*;
Mutation;
Exome Sequencing;
East Asian People
- From:
Chinese Journal of Medical Genetics
2026;43(1):19-30
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the genetic variants and phenotypic characteristics of patients with Neurofibromatosis type I (NF1).
METHODS:Twenty two NF1 patients who presented at Enze Medical (Center) Group in Taizhou between 2018 and 2024 were selected as the study subjects. Clinical phenotype and family history were collected for the patients. Whole exome sequencing (WES) was carried out for the 22 probands to screen the variants of NF1 gene. Candidate variants were verified by Sanger sequencing of their family members. This study was approved by the Medical Ethics Committee of the Hospital (Ethics No.: K20230902).
RESULTS:The 22 probands were diagnosed between the age of 5 months to 47 years old, and have all shown cafe au lait spots on their skin. Seventeen patients exhibited the phenotype at birth, and 11 had various degrees of neurofibromatosis. Among them, probands 1 and 13 underwent surgical resection of the tumor but had recurred, while proband 12 had amputation due to the huge size and serious impact of the neurofibroma and had no recurrence. Five patients had various degrees of scoliosis. In total 22 germline mutations and one somatic mutation were identified among the 22 families, with 5 variants unreported previously, including 1 nonsense mutation c.1603C>T (Q535*), 3 frameshift mutations [c.7268_7269delCA (Thr2423fs), c.2293del (Arg765Alafs*26), and c.5433_5438delinsGC (Phe1812ArgfsTer50)], and 1 deletion involving exons 41-44 of the NF1 gene and adjacent introns. Proband 13 was found to harbor germline mutation c.6796C>T (Gln2266Ter) and somatic mutation c.1019_1020del (Ser340Cysfs Ter12) in the peripheral blood and tumor tissue, respectively. Among the 22 NF1 probands, 6 had received treatment due to severe illness. Proband 1 had tumor resection in the right upper limb, but was found to have malignant lung tumor and died during follow-up. Proband 12 had multiple recurrence of neurofibroma in the left ring finger. Proband 4 underwent spinal correction surgery due to severe scoliosis. Proband 11 had died due to a central nervous system disease. Among the 22 germline mutations, 6 had led to the occurrence of truncated proteins, which may have a more severe impact on the phenotype.
CONCLUSION:This study investigated the genetic variants and clinical phenotypes of 22 NF1 families and identified 5 novel variants of the NF1 gene, which has expanded the genotypic and phenotypic spectra of the NF1. Preliminary studies have identified an association between truncated mutations, young age, and severe phenotypes, which may provide important clues for prognosis evaluation. For the clinical diagnosis and treatment of NF1, it is necessary to consider the phenotypic characteristics and genetic testing in combination with genetic counseling and long-term follow-up.
